Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyJefferson Health Plans Drug Testing Policy | OpenP…
    Ask Trek AI about this page
    CurrentPartners Insurance Company dba Jefferson Health PlansPolicy RB.044.A

    Urine Drug Testing

    Customize your policy alerts

    Sign up for partners_insurance_company_dba_jefferson_health_plans Policy RB.044.A alerts

    Get alerted when Policy RB.044.A changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs reimbursement for presumptive and definitive urine drug testing across all Jefferson Health Plans lines of business. It applies to providers and establishes covered testing, definitive-testing exceptions, documentation requirements, and Medicare Advantage coding exclusions, subject to member benefits and contracts.

    Policy Summary
    PayerPartners Insurance Company dba Jefferson Health Plans
    PolicyUrine Drug Testing
    Policy CodePolicy RB.044.A
    Change TypeNo material clinical or coverage change
    Effective Date05/14/2026
    Last ReviewApr 9, 2026
    Next Review DateN/A
    Key ActionOrder drug screening through the treating clinician and document medical necessity.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    3Presumptive testing codes covered

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    5
    Definitive testing codes subject to exceptions
    24 hoursDefinitive testing timing requirement
    4Definitive-testing drug-class bands
    14Medicare Advantage exclusions

    Coverage Criteria

    Covered Presumptive Testing Criteria

    Covered when all of the following are met:

    ALL of the following

    • Testing is used as an initial screening tool to detect prescribed, non-prescribed, or illicit substances.
    • Testing is medically necessary for clinical management of a patient receiving controlled substances or being treated for a substance use disorder.
    • Testing is ordered by the treating clinician and supported by documented medical necessity.

    Exceptions to Definitive-Testing Noncoverage

    Definitive confirmatory or quantitative testing is not covered unless at least one exception applies and the applicable requirements are met.

    At least one exception

    • Precise identification of a drug or metabolite is necessary to confirm adherence, misuse, diversion, or exposure to non-prescribed or illicit substances.

    • ALL of the following

      • The presumptive test result is positive.
      • Definitive testing is limited to substances identified as present or positive on the presumptive test.
      • The definitive test is ordered within 24 hours of the presumptive test.

    • ALL of the following

      • The presumptive test result is negative.

    Medicare Advantage Definitive-Testing Exclusions

    For Medicare Advantage claims, the following individual definitive drug-testing CPT codes and ranges are not covered:

    Do not bill CPT 80320–80331, 80345–80354, 80356–80365, 80367–80373, 80375–80377, or 83992 for definitive drug testing.

    Reimbursement Coding

    Presumptive qualitative testingCPTCovered
    80305Presumptive drug test, any number of drug classes and devices or procedures, read by direct optical observation; includes sample validation when performed, per date of service.
    80306Presumptive drug test, any number of drug classes and devices or procedures, read by instrument-assisted direct optical observation; includes sample validation when performed, per date of service.
    80307Presumptive drug test, any number of drug classes and devices or procedures, by instrument chemistry analyzers, chromatography, and/or mass spectrometry; includes sample validation when performed, per date of service.
    Definitive confirmatory or quantitative testingHCPCSNot Covered
    G0480Definitive drug testing, qualitative or quantitative, all sources, per day, for 1-7 drug classes including metabolites when performed.
    G0481Definitive drug testing, qualitative or quantitative, all sources, per day, for 8-14 drug classes including metabolites when performed.
    G0482Definitive drug testing, qualitative or quantitative, all sources, per day, for 15-21 drug classes including metabolites when performed.
    G0483Definitive drug testing, qualitative or quantitative, all sources, per day, for 22 or more drug classes including metabolites when performed.
    G0659Definitive drug testing using identification methods without method- or drug-specific calibration, matrix-matched quality control material, or stable isotope or other universally recognized internal standards; any number of drug classes, per specimen and per day.
    Medicare Advantage definitive-testing exclusionsCPTNot Covered
    80320-80331Individual definitive drug-testing CPT code range not covered for Medicare Advantage.
    80345-80354Individual definitive drug-testing CPT code range not covered for Medicare Advantage.
    80356-80365Individual definitive drug-testing CPT code range not covered for Medicare Advantage.
    80367-80373Individual definitive drug-testing CPT code range not covered for Medicare Advantage.
    80375-80377Individual definitive drug-testing CPT code range not covered for Medicare Advantage.
    83992Individual definitive drug-testing CPT code not covered for Medicare Advantage.
    Definitive Testing Order Interval
    Timing requirementOrder definitive testing within 24 hours of the presumptive test.
    Positive presumptive resultLimit definitive testing to substances identified as present or positive on the presumptive test.
    Negative presumptive resultDefinitive testing may be ordered within 24 hours when the negative finding is inconsistent with the individual’s medical history or behavior.
    G0480 Drug-Class Range
    HCPCS codeG0480
    Drug-class range1-7 drug classes

    Provider and Billing Actions

    Documentation Required

    Order testing and document medical necessity

    Order drug screening through the treating clinician and document medical necessity for clinical management of patients receiving controlled substances or being treated for a substance use disorder.

    Documentation Required

    Support medical necessity on review

    Be prepared to provide appropriate and complete documentation when the plan requests records during review. Documentation must support and validate medical necessity.

    Billing Rule

    Testing Definitions

    Definitive (Confirmatory/Quantitative) Testing
    PurposeVerifies or refutes initial screening results.
    Specificity and sensitivityMore specific and sensitive than presumptive testing.
    What it identifiesIdentifies specific drugs, drug concentrations, and associated metabolites.
    Processing and methodsResults typically take longer because specimens are processed in a laboratory; methods may include GC/MS or LC/MS.
    Presumptive (Qualitative) Testing
    Other namesAlso called an initial drug screen or point-of-care testing.
    Purpose
    Policy Summary
    PayerPartners Insurance Company dba Jefferson Health Plans
    PolicyUrine Drug Testing
    Policy CodePolicy RB.044.A
    Change TypeNo material clinical or coverage change
    Effective Date05/14/2026
    Last ReviewApr 9, 2026
    Next Review DateN/A
    Key ActionOrder drug screening through the treating clinician and document medical necessity.
    SourceLink
    On This Page
    Coverage CriteriaReimbursement CodingProvider and Billing ActionsTesting Definitions
    The finding is inconsistent with the individual's medical history or behavior.
  1. The definitive test is ordered within 24 hours of the presumptive test.
    2. Additional inclusionIncludes metabolites when performed; billed per day.
    G0481 Drug-Class Range
    HCPCS codeG0481
    Drug-class range8-14 drug classes
    Additional inclusionIncludes metabolites when performed; billed per day.
    G0482 Drug-Class Range
    HCPCS codeG0482
    Drug-class range15-21 drug classes
    Additional inclusionIncludes metabolites when performed; billed per day.
    G0483 Drug-Class Range
    HCPCS codeG0483
    Drug-class range22 or more drug classes
    Additional inclusionIncludes metabolites when performed; billed per day.

    Use presumptive testing for initial screening

    Use presumptive qualitative testing as the initial screening tool to detect prescribed, non-prescribed, or illicit substances.

    • CPT 80305, 80306, and 80307 are the listed presumptive testing codes.
    Denial Risk

    Apply definitive-testing exception criteria

    Definitive confirmatory or quantitative drug testing is not covered unless a stated exception applies. Do not expect reimbursement without meeting the applicable exception criteria.

    • The listed definitive-testing codes are G0480, G0481, G0482, G0483, and G0659.
    Documentation Required

    Establish necessity for definitive testing

    For definitive testing to qualify for reimbursement, precise identification of a drug or metabolite must be necessary to confirm adherence, misuse, diversion, or exposure to non-prescribed or illicit substances.

    Billing Rule

    Meet definitive-testing timing and scope rules

    Follow the presumptive-result, timing, and scope requirements when ordering definitive testing. After a positive presumptive result, test only substances identified as present or positive and order definitive testing within 24 hours; after a negative result, order it within 24 hours only when the finding is inconsistent with the individual’s medical history or behavior.

    Denial Risk

    Avoid Medicare Advantage definitive CPT exclusions

    For Medicare Advantage claims, do not bill the listed individual definitive drug-testing CPT codes or ranges because they are not covered and may result in inappropriate payment when individual tests are billed instead of a single comprehensive code.

    • 80320–80331
    • 80345–80354
    • 80356–80365
    • 80367–80373
    • 80375–80377
    • 83992
    Identifies possible use of a drug or drug class and detects the presence or absence of substances.
    Result typeGenerally produces a rapid positive or negative result and does not typically indicate a specific drug level.
    Testing methodInitial drug screens use immunoassay methods, using antibodies to detect drugs at the molecular level.